Dorzox Eye Drop (Dorzolamide 2%) is a carbonic anhydrase inhibitor used to lower intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
It reduces aqueous humor production in the ciliary processes, helping protect the optic nerve from progressive glaucomatous damage.
As a preserved formulation, it is widely used as first-line or adjunctive therapy in long-term glaucoma management.

• Open-angle glaucoma: Lowers IOP and prevents optic nerve damage
• Ocular hypertension: For patients with elevated IOP without optic nerve changes
• Adjunctive therapy: Can be combined with Timolol, Latanoprost
• Alternative option for patients intolerant to prostaglandin analogs

• Inhibits carbonic anhydrase II to reduce aqueous humor production
• Onset: 1–2 hours / Peak effect: 2–4 hours
• Provides stable long-term pressure control
• Effective in combination regimens
• Trusted in chronic glaucoma therapy

• Instill 1 drop, 2–3 times daily
• Do not touch the dropper tip
• Separate other eye drops by 5–10 minutes
• Remove contact lenses before use; reinsert after 15 minutes
• Shake gently if advised

• Store below 25–30°C
• Avoid moisture, heat, sunlight
• Do not freeze
• Keep tightly closed
• Discard 4 weeks after opening

Common: mild burning, blurred vision, discomfort, bitter taste
Uncommon: redness, dry eyes, eyelid irritation
Serious: corneal swelling, allergic reaction → seek immediate care